Stenosis News and Research

RSS

A stenosis is an abnormal narrowing in a blood vessel or other tubular organ or structure.

Xenogenics acquires Ideal BioStent assets

MultiCell Technologies, Inc. and its majority owned subsidiary, Xenogenics Corporation, are pleased to announce the acquisition of the Ideal™ BioStent assets by Xenogenics Corporation from investment funds managed by Western Technology Investment and Silicon Valley Bank. Xenogenics Corporation also entered into a worldwide exclusive license with Rutgers University for rights to certain intellectual property related to the Ideal™ BioStent.

19 Oct 2010

BioMarin announces BMN-111 program for treatment of achondroplasia

BioMarin Pharmaceutical Inc. today announced its program for BMN-111, a peptide therapeutic for the treatment of achondroplasia. BioMarin plans to file an IND in the fourth quarter of 2011 and to initiate a Phase 1 clinical trial by the first quarter of 2012.

19 Oct 2010

Medtronic CoreValve System IDE for transcatheter aortic valve implantation receives FDA approval

Medtronic, Inc. today announced U.S. Food and Drug Administration (FDA) conditional approval for its Investigational Device Exemption (IDE) application and pivotal clinical trial protocol to begin evaluating the Medtronic CoreValve System for transcatheter aortic valve implantation (TAVI).

15 Oct 2010

VertiFlex enrolls patients in Superion IDE clinical trial

VertiFlex, Inc., a leading innovator of minimally invasive and motion preserving spinal surgery technologies, today announced that 200 patients have been enrolled in its pivotal IDE clinical trial of the Superion Interspinous Spacer (ISS).

15 Oct 2010

Study compares minimally invasive and open surgeries for lower back pain

Rush University Medical Center is assessing whether minimally invasive surgery to relieve lower back pain differs from open surgery in terms of complication rate, recovery time, outcome and cost.

13 Oct 2010

Medtronic announces U.S. launch of VERTEX SELECT Reconstruction System Posted Screw Module

Medtronic, Inc. today announced the U.S. launch of the VERTEX SELECT® Reconstruction System Posted Screw Module. The announcement was made at the 25th Annual Meeting of the North American Spine Society (NASS) in Orlando, Fla.

6 Oct 2010

CTTC, Spero enter sales agreement for Calmare medical devices

Competitive Technologies, Inc. announced today that it has entered into a sales agreement with Spero Pain Relief Therapy, LLC. Spero, based in St. George, UT, opened its first of 14 planned pain clinics using CTTC's Calmare Pain Therapy medical device last month.

6 Oct 2010

CardioDx publishes PREDICT trial results

CardioDx, a pioneer in the field of cardiovascular genomic diagnostics, today announced publication of results from the Personalized Risk Evaluation and Diagnosis In the Coronary Tree (PREDICT) trial in the Annals of Internal Medicine, the journal of the American College of Physicians.

5 Oct 2010

Benicar better than Cozaar in reducing blood pressure: Study

New study results show that patients treated with Benicar® (olmesartan medoxomil) 40 mg once daily had significantly greater reductions in blood pressure and higher rates of goal attainment than patients receiving Cozaar® (losartan potassium) 100 mg once daily at week 8, according to findings of a new head-to-head study presented today at the late breaker session at the 23rd Scientific Meeting of the International Society of Hypertension (ISH) in Vancouver, Canada.

1 Oct 2010

NIH funds $1.5M for research into prediction of stroke risk in pediatric patients with sickle cell disease

A researcher from the biomedical engineering department operated by Georgia Tech and Emory University has received a $1.5 million NIH Director's New Innovator Award to support a project aimed at reducing the incidence of stroke in children with sickle cell disease. Manu Platt, an assistant professor in the Wallace H. Coulter Department of Biomedical Engineering, will use the National Institutes of Health (NIH) funding to develop models for identifying which children with the disease are at risk for stroke.

1 Oct 2010

Wenzel Spine receives FDA marketing clearance for VariLift Expandable Interbody Fusion System

Wenzel Spine, Inc., a medical device company focused on offering less invasive, stand-alone alternatives to traditional spinal fusion, today announced they have received 510K clearance to market the VariLift Expandable Interbody Fusion System.

30 Sep 2010

Cedars-Sinai physicians to lead St. Jude Medical's transcatheter aortic valve implantation clinical trial

St. Jude Medical, Inc., a global medical device company, today announced that physicians from the Cedars-Sinai Heart Institute will lead the company's transcatheter aortic valve implantation (TAVI) clinical trial. The study will evaluate the safety and efficacy of the St. Jude Medical transcatheter aortic valve for patients who experience severe aortic stenosis and who may be at an elevated risk for open-heart surgery.

29 Sep 2010

Ready-to-Use Cardene I.V. lowers acutely elevated blood pressure: CLUE study

Results from the CLUE study, a head-to-head comparison between Ready-to-Use Cardene I.V. (nicardipine) and labetalol in the emergency room, showed that Ready-to-Use Cardene I.V. lowers acutely elevated blood pressure more effectively than labetalol. These data were presented today at the annual meeting of the American College of Emergency Physicians (ACEP) in Las Vegas, Nevada.

29 Sep 2010

NIH Stroke Scale helps to predict mortality risk in hospitalized stroke patients

A new study finds a risk model developed using Get With The Guidelines-Stroke data is a practical bedside tool that can identify patients at the highest risk for dying when hospitalized after a stroke.

28 Sep 2010

Johnson & Johnson acquires Marus Endovascular

Johnson & Johnson today announced that it has completed the acquisition of Micrus Endovascular, a global developer and manufacturer of minimally invasive devices for hemorrhagic and ischemic stroke. Johnson & Johnson announced its agreement to acquire Micrus on July 12, 2010.

28 Sep 2010

Early recipient of transcatheter aortic valve receives Courageous Patient Award

Lillian Feldshuh, of Scarsdale, NY, an early recipient of a transcatheter aortic valve in 2006, received the Courageous Patient Award yesterday at the Transcatheter Cardiovascular Therapeutics scientific symposium in Washington, DC. The procedure was a success and Feldshuh, who will turn 100 years in just 7 months, remains in good health.

27 Sep 2010

Astellas Pharma announces Phase IV study results of Lexiscan injection at ASNC session

Today Astellas Pharma US, Inc. announced results of a Phase IV study showing Lexiscan(regadenoson) Injection was comparable to placebo in causing a >15% decrease in forced expiratory volume in one second (FEV1) in subjects with asthma or chronic obstructive pulmonary disease (COPD) who are likely candidates for myocardial perfusion imaging (MPI) studies.

27 Sep 2010

Cook Medical submits PMA to FDA for new balloon expandable stent for renal artery disease

Cook Medical has submitted its Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its new balloon expandable stent for renal artery disease. Intended for patients suffering from renal artery stenosis, a narrowing of the arteries that supply blood to the kidneys, the new device features a low profile design and does not shorten upon expansion.

24 Sep 2010

New EID/Qb technique offers real-time monitoring of AVF function during dialysis

A simple equation provides real-time feedback to detect access recirculation in arteriovenous fistulas (AVFs) during hemodialysis, reports a study in the September/October issue of ASAIO Journal, Official Journal of the American Society of Artificial Internal Organs.

24 Sep 2010

TAVI procedure reduces mortality rate in patients with aortic stenosis

Just released data from a clinical trial shows promise for a new minimally invasive treatment option for patients with severe aortic stenosis who are too sick for traditional forms of open-heart surgery. As compared to standard medical therapy, the new procedure, transcatheter aortic valve implantation (TAVI), significantly reduced mortality rates in patients who received the new valve.

24 Sep 2010

Stenosis News and Research

Xenogenics acquires Ideal BioStent assets

BioMarin announces BMN-111 program for treatment of achondroplasia

Medtronic CoreValve System IDE for transcatheter aortic valve implantation receives FDA approval

VertiFlex enrolls patients in Superion IDE clinical trial

Study compares minimally invasive and open surgeries for lower back pain

Medtronic announces U.S. launch of VERTEX SELECT Reconstruction System Posted Screw Module

CTTC, Spero enter sales agreement for Calmare medical devices

CardioDx publishes PREDICT trial results

Benicar better than Cozaar in reducing blood pressure: Study

NIH funds $1.5M for research into prediction of stroke risk in pediatric patients with sickle cell disease

Wenzel Spine receives FDA marketing clearance for VariLift Expandable Interbody Fusion System

Cedars-Sinai physicians to lead St. Jude Medical's transcatheter aortic valve implantation clinical trial

Ready-to-Use Cardene I.V. lowers acutely elevated blood pressure: CLUE study

NIH Stroke Scale helps to predict mortality risk in hospitalized stroke patients

Johnson & Johnson acquires Marus Endovascular

Early recipient of transcatheter aortic valve receives Courageous Patient Award

Astellas Pharma announces Phase IV study results of Lexiscan injection at ASNC session

Cook Medical submits PMA to FDA for new balloon expandable stent for renal artery disease

New EID/Qb technique offers real-time monitoring of AVF function during dialysis

TAVI procedure reduces mortality rate in patients with aortic stenosis

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News